Beltrán de Paz Claudia, Flores Sandoval Graciela, Orea Solano Modesto, Gómez Vera Javier, Serrano Miranda Ernestina, Sevilla Flores Patricia, Juárez Rojas Yurhixy, Estrada Parra Sergio
Departamento de Alergia e Inmunología Clínica, Hospital Lic. Adolfo López Mateos, ISSSTE, Avenida Universidad 132, Col. Florida, CP 01414, México, DF.
Rev Alerg Mex. 2003 Mar-Apr;50(2):54-9.
The atopic dermatitis is a chronic disease with immunological alterations, neuro-immune-endocrine implications and repercussions in the psyche.
To determine the effectiveness of the use of psychological support in the treatment of atopic dermatitis.
This study included 20 patients (from 15 to 50 years old) with moderated and severe atopic dermatitis based on the Hanifin and Rafka modified criteria. They were classified in three groups of treatment: A) 10 patients with transfer factor and psychological support, B) 10 with transference factor without psychological support, C) 10 healthy individuals as a control group. At the beginning and ending of the analysis the degree of severity of the illness was determined using the SCORAD scale.
There was a more statistically significant clinical improvement on group A than in group B, besides a decrease in anxiety and depression, at a laboratory level including hormonal behavior, without meaningful changes.
It was demonstrated that the treatment with immune-modulator and psychological support on the moderated and severe atopic dermatitis improves the clinical and immunological evolution of this illness.
